EMILY S PARKER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Women's Health GRAND RAPIDS, MI NPI 1639404288

General Payments — all program years on this page

$2,244.99

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 83
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $422.84 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $422.8420

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $507.805
2022 $956.4340
2023 $357.9218
2024 $422.8420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078749021 Janssen Biotech, Inc. $17.93 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1085810540 SpringWorks Therapeutics, Inc. $20.45 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091964876 Ipsen Biopharmaceuticals, Inc $25.52 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093886261 Alexion Pharmaceuticals, Inc. $34.64 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104643105 AstraZeneca Pharmaceuticals LP $15.20 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107789498 ABBVIE INC. $14.27 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107789503 ABBVIE INC. $26.36 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116485789 GlaxoSmithKline, LLC. $22.92 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116591685 GlaxoSmithKline, LLC. $20.52 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126835556 Genmab U.S., Inc. $26.08 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131372992 PFIZER INC. $13.22 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133704912 Gilead Sciences, Inc. $21.28 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133704914 Gilead Sciences, Inc. $21.22 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137302584 PharmaEssentia USA Corporation $13.91 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141591796 Merck Sharp & Dohme LLC $26.23 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144981600 Takeda Pharmaceuticals U.S.A., Inc. $33.03 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145877839 Deciphera Pharmaceuticals Inc. $17.67 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147107262 Acrotech Biopharma Inc. $18.95 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154831700 Pharmacosmos Therapeutics Inc. $16.54 02/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154831702 Pharmacosmos Therapeutics Inc. $16.90 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.